Search Results - "Saleh, Aljona"
-
1
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Published in Nature communications (16-03-2018)“…The development of non-genotoxic therapies that activate wild-type p53 in tumors is of great interest since the discovery of p53 as a tumor suppressor. Here we…”
Get full text
Journal Article -
2
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Published in Nature communications (18-08-2023)Get full text
Journal Article -
3
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Published in Nature communications (22-05-2018)“…The original PDF version of this Article listed the authors as “Marcus J.G.W. Ladds,” where it should have read “Marcus J. G. W. Ladds, Ingeborg M. M. van…”
Get full text
Journal Article -
4
Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (01-08-2022)“…•Rapid, sensitive methods for high-throughput analysis of drugs in human breast milk.•Simultaneous milk quantification of cetirizine, venlafaxine,…”
Get full text
Journal Article -
5
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Published in Nature (London) (10-04-2014)“…Cancers have dysfunctional redox regulation resulting in reactive oxygen species production, damaging both DNA and free dNTPs. The MTH1 protein sanitizes…”
Get full text
Journal Article -
6
Validation and development of MTH1 inhibitors for treatment of cancer
Published in Annals of oncology (01-12-2016)“…Different MTH1 inhibitors have different ability to kill cancer cells. Here we demonstrate that the lack of efficiency of some MTH1 inhibitors is explained by…”
Get full text
Journal Article -
7
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
Published in Journal of medicinal chemistry (23-04-2020)“…Human dihydroorotate dehydrogenase (DHODH), an enzyme in the de novo pyrimidine synthesis pathway, is a target for the treatment of rheumatoid arthritis and…”
Get full text
Journal Article -
8
Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography–time-of-flight mass spectrometry
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (15-11-2012)“…► A multi target analytical approach for clinical drugs of abuse screening was explored. ► The analysis time was short. ► The selectivity was based on high…”
Get full text
Journal Article -
9
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies (Adv. Therap. 7/2022)
Published in Advanced therapeutics (01-07-2022)Get full text
Journal Article -
10
Abstract 2890: The development of an Adaptable Drug Affinity Conjugate (ADAC) targeting CD40 for a flexible therapeutic peptide cargo delivery to dendritic cells
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract CD40 agonistic antibodies targeting antigen-presenting cells rely on simultaneous antigen presentation for optimal efficacy, as the co-stimulatory…”
Get full text
Journal Article -
11
Development and validation of method for TH588 and TH287, potent MTH1 inhibitors and new anti-cancer agents, for pharmacokinetic studies in mice plasma
Published in Journal of pharmaceutical and biomedical analysis (01-02-2015)“…•A bioanalytical method was developed for quantification of MTH1 inhibitors, TH588 and TH287.•Method was validated for TH588 and TH287 and their metabolite in…”
Get full text
Journal Article -
12
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
Published in Advanced therapeutics (01-07-2022)“…The agonistic potentials of therapeutic anti‐CD40 antibodies have been profiled in relation to antibody isotype and epitope specificity. Still, clinical impact…”
Get full text
Journal Article -
13
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
Published in NATURE COMMUNICATIONS (22-05-2018)Get full text
Publication -
14
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool (vol 508, pg 215, 2014)
Published in NATURE (27-04-2017)Get full text
Publication -
15
Digestion of Enolase and Carbonic Anhydrase as Model Proteins for Therapeutic Proteins in Blood Plasma with Immobilized Thermolysin and Quantification of Some of the Peptides by LC/LC–MS/MS
Published in Chromatographia (2014)“…There is a need for fast method development in the early drug discovery phase of therapeutic proteins. Thermolysin has not been used for quantification of…”
Get full text
Journal Article -
16
Correction: Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Published in Nature (London) (27-04-2017)“…Nature 508, 215–221 (2014); doi:10.1038/nature13181 In this Article, the structure of compound TH650 (4) in Fig. 4a was drawn incorrectly; the correct…”
Get full text
Journal Article -
17
Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Published in Nature (London) (26-04-2017)Get full text
Journal Article -
18
Bioanalytical Method for Quantification of Thioredoxins in Bacillus anthracis by Digestion with Immobilized Pepsin and LC–MS/MS and On-line LC/LC–MS/MS
Published in Chromatographia (2016)“…We describe a method for the quantification of proteins in a biological matrix through digestion with pepsin. Pepsin is a gastric protease that efficiently…”
Get full text
Journal Article